This episode of Lung Cancer Considered focuses on radiopharmaceuticals-- a unique class of drugs that may have the most immediate impact in neuroendocrine tumors. Host Dr. Stephen Liu leads a discussion with three respected international clinicians about how these therapies play a role in both diagnostics and therapeutics and how they may soon be expanding.
Podkasten Lung Cancer Considered er innebygd på denne siden fra en åpen RSS feed. Alle filer, beskrivelser, illustrasjoner og andre metadata fra RSS-feeden tilhører podcasteieren og er ikke tilknyttet eller validert av Podplay.